Ventricular Assist Devices Market Size will Observe Substantial Growth by 2028

Ventricular Assist Devices Market
Ventricular Assist Devices Market

Ventricular assist devices are external devices that are attached to a patient's body and assist in the pumping of blood throughout the entire body. It is primarily utilised in the treatment of heart failure patients. It's a high-tech device that simulates the heart's function. Heart failure occurs when the heart muscles weaken and the heart is unable to pump enough blood to the body. Heart failure is caused by a variety of disorders including heart attacks, high blood pressure, faulty heart valves, irregular heart rhythms, diabetes, and chronic renal and lung diseases.

The rising prevalence of heart failure is driving the market for ventricular assist devices to grow. According to a research published in the Lancet in 2017 called the Global Burden of Disease, heart failure affects approximately 26 million individuals worldwide. In addition, the rising prevalence of cardiovascular disorders, which lead to heart failure, is driving up demand for Ventricular Assist Devices Market. According to a World Health Organization factsheet from 2016, 17.7 million people died each year from cardiovascular illness, with ischemic heart disease, which includes heart failure, accounting for nearly 46% of these deaths. Other diseases, such as diabetes, are leading to the development of heart failure, which is fueling the market for ventricular assist devices.

According to the International Diabetes Federation's (IDF) Diabetes Atlas 2017, there were approximately 425 million diabetic individuals worldwide in 2017. According to figures released by the American Heart Association in 2018, 68 percent of diabetics aged 65 and older are at risk of dying from heart disease. Heart disease is caused by a sedentary lifestyle, lack of exercise, bad eating habits, and drunkenness. The Ventricular Assist Devices Market is predicted to develop in response to a growing lack of cardiac donors for transplantation.

Due to a lack of donors, only about 0.01-0.49 per million heart transplant procedures are conducted each year in emerging countries, according to a report issued by the Global Observatory on Donations and Transplantation in 2015. The Ventricular Assist Devices Market is also growing because to continuous improvements in design, efficiency, and dependability. For example, Abiomed Inc. received Pre-Market Approval (PMA) from the US Food and Drug Administration (FDA) in April 2018 for its Impella CP heart pump with smart assist technology, which uses an optical sensor. It's a cutting-edge device that'll boost productivity, convenience of use, and patient management.

Comments

Popular posts from this blog

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

Artificial Intelligence And Machine Learning Are Fueling Growth Of Assessment Services Market